| CAS ID: | |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Monoclonal antibody |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT00581997 | Disease | Pulmonary fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | December 28, 2007 | Last Verified | May 4, 2012 |
| Sponsor | Novartis Pharmaceuticals | ||
Trial Record 2
| ClinicalTrial ID | NCT00581997 | Disease | Systemic sclerosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | December 28, 2007 | Last Verified | May 4, 2012 |
| Sponsor | Novartis Pharmaceuticals | ||
Trial Record 3
| ClinicalTrial ID | NCT00532233 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 20, 2007 | Last Verified | June 22, 2017 |
| Sponsor | Novartis Pharmaceuticals | ||
Trial Record 4
| ClinicalTrial ID | NCT01266135 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | December 24, 2010 | Last Verified | April 15, 2015 |
| Sponsor | Novartis Pharmaceuticals | ||
Trial Record 5
| ClinicalTrial ID | NCT00987545 | Disease | Keloid |
| Phase | Phase 2 | Status | Terminated |
| First Received | October 1, 2009 | Last Verified | May 4, 2012 |
| Sponsor | Novartis Pharmaceuticals | ||